Condition: Cancer · Sponsor: Lee's Pharmaceutical Limited
This study is a single-dose, open-label, 2-cycle crossover design, comparing the pharmacokinetic parameters and safety of Inhaled Fentanyl Aerosol and intravenous fentanyl injection.
This description comes directly from the study's public registry record.
Haiyan Hu, doctor · +86 18930174575 · xurill@163.com
Always discuss trial participation with your own doctor first.
| Henan Tumor Hospital | Zhengzhou, Henan, China | Recruiting |
| Shanghai Sixth People's Hospital | Shanghai, Shanghai Municipality, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06953453